Photoimmunotherapy such as extracorporeal Photopheresis (ECP) is a promising Strategy to treat GvHD after CAR-T Cell Therapy

被引:0
|
作者
Han, H. [1 ]
Wang, L. [1 ]
Neuber, B. [1 ]
Ding, Y. [1 ]
Lin, M. [1 ]
Yao, H. [1 ]
Chen, Q. [1 ]
He, B. [1 ,2 ]
Wang, S. [1 ,3 ]
Sauer, T. [1 ]
Schubert, M. -L [1 ]
Kunz, A. [1 ]
Huckelhoven-Krauss, A. [1 ]
Keib, A. [1 ]
Kleist, C. [4 ]
Muller-Tidow, C. [1 ,5 ]
Dreger, P. [1 ,5 ]
Schmitt, M. [1 ,5 ]
Schmitt, A. [1 ]
机构
[1] Heidelberg Univ, Univ Clin Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[2] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China
[3] First Affiliated Hosp Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Nanjing, Peoples R China
[4] Heidelberg Univ, Univ Clin Heidelberg, Dept Nucl Med, Heidelberg, Germany
[5] Natl Ctr Tumor Dis, German Canc Consortium, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P381
引用
收藏
页码:123 / 123
页数:1
相关论文
共 50 条
  • [1] EXTRACORPOREAL PHOTOPHERESIS CONSTITUTES A PROMISING STRATEGY FOR THE TREATMENT OF GVHD AFTER CAR-T CELL THERAPY
    Han, Huixiu
    Wang, Lei
    Neuber, Brigitte
    Ding, Yuntian
    Lin, Min
    Yao, Hao
    Chen, Qian
    He, Bailin
    Wang, Sanmei
    Sauer, Tim
    Schubert, Maria-Luisa
    Kunz, Alexander
    Hueckelhoven-Krauss, Angela
    Keib, Anna
    Kleist, Christian
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Schmitt, Anita
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 225 - 225
  • [2] Extracorporeal photopheresis (ECP) to treat GvHD
    Hackstein, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 231 - 232
  • [3] Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy
    Han, Huixiu
    Wang, Lei
    Ding, Yuntian
    Neuber, Brigitte
    Hueckelhoven-Krauss, Angela
    Lin, Min
    Yao, Hao
    Chen, Qian
    Sauer, Tim
    Schubert, Maria-Luisa
    Guo, Zhiqiang
    Mueller-Tidow, Carsten
    Schmitt, Michael
    Schmitt, Anita
    BLOOD ADVANCES, 2024, 8 (11) : 2675 - 2690
  • [4] GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation - successfully treated by extracorporeal photopheresis
    Farid, Kiavasch Mohammad Nejad
    Bug, Gesine
    Schmitt, Anita
    Lang, Fabian
    Schubert, Maria-Luisa
    Haberkorn, Uwe
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] Extracorporeal Photopheresis (ECP) increases the number and suppressive function of regulatory T cells in GvHD patients
    Schmitt, S.
    Mahnke, K.
    Kretz, M.
    Karakhanova, S.
    Enk, A. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 171 - 172
  • [6] Earlier may be better: the role of extracorporeal photopheresis (ECP) as prevention of GVHD after allogeneic transplant
    Choe, Hannah K.
    van Besien, Koen
    LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 272 - 273
  • [7] Radiation Therapy as a Bridging Strategy in CAR-T Cell Therapy and the Impact of Tumor Control Status at CAR-T Cell Infusion
    Shimizuguchi, T.
    Kanemasa, Y.
    Yagi, Y.
    Hayakawa, S.
    Taguchi, K.
    Ito, K.
    Murofushi, K.
    Sasaki, Y.
    Nakamura, S.
    Matsuda, S.
    Shimoyama, T.
    Toya, T.
    Shimizu, H.
    Najima, Y.
    Kobayashi, T.
    Doki, N.
    Haraguchi, K.
    Okuyama, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S207 - S207
  • [8] Extracorporeal photopheresis (ECP) as treatment for cutaneous T-cell lymphoma (CTCL).
    Nazari, NE
    TRANSFUSION, 1998, 38 (10) : 7S - 7S
  • [9] Extracorporeal photopheresis (ECP) as treatment for cutaneous T-cell lymphoma (CTCL).
    King, L
    BLOOD, 1998, 92 (10) : 237B - 237B
  • [10] How I treat adverse effects of CAR-T cell therapy
    Yanez, Lucrecia
    Alarcon, Ana
    Sanchez-Escamilla, Miriam
    Perales, Miguel-Angel
    ESMO OPEN, 2019, 4